Technology & Engineering

Research

The Latest

New Electric Vehicle Chargers Help Usher in the Future of Electric Vehicle Charging

Home to nearly half of the nation’s plug-in electric vehicles, California has emerged as a leader in embracing clean car technology and infrastructure. Now, thanks to research funding from the California Energy Commission, the next generation of electric vehicle charging stations has been commissioned at the University of California, San Diego and are being used to test a new form of data communication between electric vehicles, charging stations and the power grid.

Albert La Spada Receives Harrington Scholar Award to Combat Neurodegenerative Disease

Albert La Spada, MD, PhD, professor of pediatrics, cellular and molecular medicine and neurosciences at University of California, San Diego School of Medicine, has received a 2015 Harrington Scholar award to advance his work on a therapy for Spinocerebellar ataxia type 7 (SCA7), a rare but devastating neurological disorder that can lead to blindness and progressive loss of physical coordination.

GERD Study Offers Minimally Invasive Procedure at No Cost

Approximately 20 million Americans will experience some type of gastroesophageal reflux disease, or GERD, in their lives. In some cases, patients suffer resulting heart burn or acid regurgitation so severe that they require surgery to repair damage to their esophagus. A clinical trial at UC San Diego Health is using a new, FDA-approved device that reconstructs the esophagus through the mouth and requires no incisions.

UC San Diego an ‘Upward-Mobility Machine,’ According to New York Times

The New York Times has named the University of California, San Diego the nation’s No. 4 school in its College Access Index, measuring which colleges and universities do the most for low-income students.

UC San Diego to Host Robotics Leaders at Forum Focused on Future of Robotic Systems

On October 30, 2015, the University of California, San Diego will host a one-day event focused on the future of robotics for medicine, autonomous vehicles, first-response scenarios, consumer applications and more.

Down Syndrome Research Untangles Therapeutic Possibilities for Alzheimer’s

More than five million Americans are living with Alzheimer’s disease (AD). Of them, 400,000 also have Down syndrome. Both groups have similar looking brains with higher levels of the protein beta amyloid. In fact, patients with Down syndrome develop the abnormal protein at twice the rate. Results of a pilot study confirms the pathogenic role of beta amyloid in dementia as seen in both AD and Down syndrome.